CORONA Remedies Limited (NSE:CORONA)
India · Delayed Price · Currency is INR 2,098.20
-14.80 (-0.70%)
At close: Jul 27, 2026
CORONA Remedies Financials Overview
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 14,032 | 14,032 | 11,964 | 10,145 | 8,841 | 6,173 |
Revenue Growth | 20.08% | 17.28% | 17.94% | 14.75% | 43.20% | 7.14% |
Gross Profit Gross Profit Growth | 11,312 | 11,312 | 9,533 | 7,812 | 6,685 | 4,678 |
Operating Income Operating Income Growth | 2,561 | 2,561 | 2,035 | 1,278 | 1,079 | -25.87 |
Net Income Net Income Growth | 1,851 | 1,851 | 1,494 | 905.03 | 849.29 | -4 |
Earnings Per Share EPS Growth | 30.27 | 30.27 | 24.43 | 14.80 | 14.57 | -0.08 |
EPS Growth | 31.66% | 23.90% | 65.09% | 1.59% | - | - |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
India India Growth | 13,463 | 13,463 | 11,525 | 9,802 | 8,522 | 5,951 |
outside India outside India Growth | 569.1 | 569.1 | 439.6 | 342.46 | 318.89 | 221.88 |
Total Total Growth | 14,032 | 14,032 | 11,964 | 10,145 | 8,841 | 6,173 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 288.3 | 288.3 | 680.4 | 45.54 | 204.63 | 138.16 |
Total Debt Total Debt Growth | 1,649 | 1,649 | 862.4 | 1,590 | 279.6 | 464.05 |
Net Cash (Debt) Net Cash Growth | -1,360 | -1,360 | -182 | -1,544 | -74.97 | -325.89 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -22.24 | -22.24 | -2.98 | -25.25 | -1.29 | -6.38 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 2,295 | 2,295 | 1,905 | 1,568 | 1,027 | 977.05 |
Capital Expenditures CapEx Growth | -1,741 | -1,741 | -916.6 | -2,863 | -947.58 | -340.07 |
Free Cash Flow Free Cash Flow Growth | 553.5 | 553.5 | 988.3 | -1,296 | 79.42 | 636.98 |
Free Cash Flow Growth | -46.06% | -43.99% | - | - | -87.53% | 84.55% |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 80.62% | 80.62% | 79.68% | 77.00% | 75.61% | 75.78% |
Operating Margin | 18.25% | 18.25% | 17.01% | 12.60% | 12.21% | -0.42% |
Pretax Margin | 17.13% | 17.13% | 16.59% | 11.68% | 12.54% | -0.13% |
Profit Margin | 13.19% | 13.19% | 12.49% | 8.92% | 9.61% | -0.07% |
FCF Margin | 3.94% | 3.94% | 8.26% | -12.77% | 0.90% | 10.32% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 28, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 10.000 | 10.000 | 7.310 | 3.700 | 2.770 | 1.140 |
Dividend Per Share Growth | 0% | 36.80% | 97.57% | 33.57% | 142.98% | -0.26% |
Dividend Yield | 0.47% | 0.65% | - | - | - | - |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 28, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 69.32 | 51.41 | - | - | - | - |
Forward PE | 51.33 | 40.71 | - | - | - | - |
P/FCF Ratio | 231.84 | 171.93 | - | - | - | - |
PS Ratio | 9.15 | 6.78 | - | - | - | - |